The reported rates for non melanoma skin cancers and lymphomas are approximately 0.2 and 0.4 per 1,000 patient years, respectively (see section 4.4).

Me

The reported rates for non melanoma skin cancers and lymphomas are approximately 0.2 and 0.4 per 1000 patient years, respectively (see section 4.4).

) Extriplex joaquiniana (A.Nelson) E.H.Zacharias (Syn.

See section 6.5 for the number of doses per vial.

See section 6.5 for the number of doses per vial.

See section 6.5 for the number of doses per vial.

The solution contains benzyl alcohol 9 mg ml as a preservative (see section 4.4).

Over long term treatment, the incidence of serious infection was 1.8 per 100 patient years (see section 4.).

The S8 was extended from Winterthur to Weinfelden, providing with the existing S30 services two trains an hour on the line.

Phenylalanine (up to 0.3 mg syringe) Sodium (less than 1 mmol syringe)

A dose of 0.035 mg kg body weight per day (1 mg m2 body surface area per day) is usually recommended until final height is reached (see section 5.1).

If, during treatment, resting heart rate decreases persistently below 50 bpm or the patient experiences symptoms related to bradycardia such as dizziness, fatigue or hypotension, the dose must be titrated downward or treatment discontinued if heart rate below 50 bpm or symptoms of bradycardia persist (see section 4.2).

If, during treatment, resting heart rate decreases persistently below 50 bpm or the patient experiences symptoms related to bradycardia such as dizziness, fatigue or hypotension, the dose must be titrated downward or treatment discontinued if heart rate below 50 bpm or symptoms of bradycardia persist (see section 4.2).

Thereafter the dose should be reduced by 0.264 mg of base (0.375 mg of salt) per day (see section 4.4).

Experience with celecoxib in FAP patients below the age of 18 years is limited to a single pilot study in a very small population, in which patients were treated with celecoxib at doses up to 16 mg kg daily, which corresponds to the recommended adult FAP dose of 800 mg daily (see section 5.1).

Reduced dose (50 )

Dose per

Reduced dose

Enter one symbol specification per line. For information on symbol specifications, see section 4.5 of the gprof info page.

In severe infections the daily dose of 80 mg per kg bodyweight must not be exceeded, except in meningitis (see section 4.2.

(d) the criteria applicable for establishing the indicative breakdown of funds among the Member States for the purpose of the actions to be managed according to selection procedure A (Annex I, Section III)

The estimated daily infant dose on a mg kg basis is approximately 0.14 of the maternal dose (see section 5.2).

Following organ transplantation a starting dose of 20 mg per day is recommended in patients receiving immunosuppressive therapy (see section 4.5).

(see section 4.3, section 4.4, and section 5.2).

By the week or by the pound?

1.2 mg vial (corresponding to 60 KIU vial), 2.4 mg vial (corresponding to 120 KIU vial) or 4.8 mg vial (corresponding to 240 KIU vial).

98 (corresponding to 100 KIU vial) or 5 mg vial (corresponding to 250 KIU vial).

section create a new section.

In adolescents, children and infants, use of stavudine is supported by evidence from adequate and well controlled studies in adults with additional pharmacokinetic and safety data in paediatric patients (see also sections 4.8 and 5.2).

Biograstim and chemotherapy The usual dose is 0.5 million international units (MIU) per kilogram of bodyweight each day.

Biograstim and bone marrow transplantation The usual starting dose is 1 million international units (MIU) per kilogram of bodyweight each day.

54 The usual starting dose is between 0.1 and 0.4 million international units (MIU) per kilogram bodyweight each day.

Biograstim and peripheral blood stem cell mobilisation If you are donating stem cells for yourself, the usual dose is 0.5 million to 1 million international units (MIU) per kilogram bodyweight each day.

If you are acting as a stem cell donor for another person, the usual dose is 1 million international units (MIU) per kilogram bodyweight each day.

Filgrastim ratiopharm and chemotherapy The usual dose is 0.5 million international units (MIU) per kilogram of bodyweight each day.

Filgrastim ratiopharm and bone marrow transplantation The usual starting dose is 1 million international units (MIU) per kilogram of bodyweight each day.

54 Filgrastim ratiopharm and neutropenia in patients with HIV infection The usual starting dose is between 0.1 and 0.4 million international units (MIU) per kilogram bodyweight each day.

Filgrastim ratiopharm and peripheral blood stem cell mobilisation If you are donating stem cells for yourself, the usual dose is 0.5 million to 1 million international units (MIU) per kilogram bodyweight each day.

Ratiograstim and chemotherapy The usual dose is 0.5 million international units (MIU) per kilogram of bodyweight each day.

Ratiograstim and bone marrow transplantation The usual starting dose is 1 million international units (MIU) per kilogram of bodyweight each day.

55 Ratiograstim and neutropenia in patients with HIV infection The usual starting dose is between 0.1 and 0.4 million international units (MIU) per kilogram bodyweight each day.

Ratiograstim and peripheral blood stem cell mobilisation If you are donating stem cells for yourself, the usual dose is 0.5 million to 1 million international units (MIU) per kilogram bodyweight each day.

Tevagrastim and chemotherapy The usual dose is 0.5 million international units (MIU) per kilogram of bodyweight each day.

Tevagrastim and bone marrow transplantation The usual starting dose is 1 million international units (MIU) per kilogram of bodyweight each day.